000 01296 a2200313 4500
005 20250515090758.0
264 0 _c20080528
008 200805s 0 0 eng d
022 _a1468-2044
024 7 _a10.1136/adc.2007.131334
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSinha, Rajiv
245 0 0 _aShould gonadotropin releasing hormone analogue be administered to prevent premature ovarian failure in young women with systemic lupus erythematosus on cyclophosphamide therapy?
_h[electronic resource]
260 _bArchives of disease in childhood
_cMay 2008
300 _a444-5 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAcute Kidney Injury
_xcomplications
650 0 4 _aAdolescent
650 0 4 _aAntineoplastic Agents, Alkylating
_xadverse effects
650 0 4 _aCyclophosphamide
_xadverse effects
650 0 4 _aFemale
650 0 4 _aGonadotropin-Releasing Hormone
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aLupus Erythematosus, Systemic
_xdrug therapy
650 0 4 _aPrimary Ovarian Insufficiency
_xchemically induced
700 1 _aDionne, Janis M
773 0 _tArchives of disease in childhood
_gvol. 93
_gno. 5
_gp. 444-5
856 4 0 _uhttps://doi.org/10.1136/adc.2007.131334
_zAvailable from publisher's website
999 _c17430445
_d17430445